amphetamine and sr 48692

amphetamine has been researched along with sr 48692 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brun, P; Fournier, M; Le Fur, G; Mons, G; Rodier, D; Soubrié, P; Souilhac, J; Steinberg, R; Terranova, JP1
Perron, S; Rompré, P1
Costa, FG; Felicio, LF; Frussa-Filho, R1
Deutch, AY; Dobner, PR; Fadel, J1
Canteras, NS; Costa, FG; Felicio, LF; Frussa-Filho, R; Valera, AG1

Other Studies

5 other study(ies) available for amphetamine and sr 48692

ArticleYear
SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission.
    Neuroscience, 1994, Volume: 59, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Dopamine; Male; Motor Activity; Neurotensin; Nucleus Accumbens; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Synaptic Transmission; Tegmentum Mesencephali

1994
Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization.
    Neuropharmacology, 2000, Jul-24, Volume: 39, Issue:10

    Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Motor Activity; Neurotensin; Pyrazoles; Quinolines; Rats; Rats, Long-Evans; Receptors, Neurotensin; Time Factors

2000
The neurotensin receptor antagonist, SR48692, attenuates the expression of amphetamine-induced behavioural sensitisation in mice.
    European journal of pharmacology, 2001, Sep-28, Volume: 428, Issue:1

    Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Female; Mice; Motor Activity; Pyrazoles; Quinolines; Receptors, Neurotensin; Synaptic Transmission

2001
Amphetamine-elicited striatal Fos expression is attenuated in neurotensin null mutant mice.
    Neuroscience letters, 2006, Jul-10, Volume: 402, Issue:1-2

    Topics: Amphetamine; Analysis of Variance; Animals; Cell Count; Central Nervous System Stimulants; Corpus Striatum; Drug Interactions; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neurotensin; Oncogene Proteins v-fos; Pyrazoles; Quinolines

2006
Blockade of neurotensin receptors during amphetamine discontinuation indicates individual variability.
    Neuropeptides, 2007, Volume: 41, Issue:2

    Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Exploratory Behavior; Immunohistochemistry; Limbic System; Male; Mice; Motor Activity; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Pyrazoles; Quinolines; Receptors, Neurotensin; Substance Withdrawal Syndrome

2007